Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
Regeneron Co-founder Warns of Harms From Weight-loss Drugs: FT
How can dividend investors participate in the Chinese market?
The decline in interest rates in the usa and the accelerated growth of the economy in china provide investors seeking dividend income with a wide range of investment targets.
Can Novo, Lilly Take Credit for U.S. Obesity Rate Decline?
Trending Stocks This Week as Strong Jobs Report Underscore Resilience of U.S. Economy
Weekend reading | merck's 'harem battle'
为了让K药价值持续放大,默沙东开启了一场全球ADC寻觅之旅。
Novo Nordisk's Options: A Look at What the Big Money Is Thinking
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
EU Regulators Reviewing Safety of Finasteride, Dutasteride
Evaluating Eli Lilly Against Peers In Pharmaceuticals Industry
England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access
Johnson & Johnson Halts Mid-stage Study for Dengue Antiviral
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Thermo Fisher Plant Making Astra/ Sanofi RSV Drug Reportedly Breached FDA Rules
Futu Morning Post | Fund managers are entering the Chinese stock market at a record speed! The 'China Dragon' ETF lands in the US stock market; foreign capital accelerates its positions! Morgan Stanley increases its shareholding in BYD and other companies
The size of the USA money market fund has reached a record $6.46 trillion; Biden's vague stance has sparked an energy storm, causing international oil prices to soar by over 5%; just after raising funds, OpenAI secured a $4 billion credit line, with liquid assets exceeding over $10 billion.
US regulators said eli lilly and co's weight loss miracle drug is no longer in short supply, causing "平替" manufacturer Hims & Hers to drop nearly 10%.
FDA stated that eli lilly and co's two exenatide-containing GLP-1 injection Zepbound and Mounjaro have been in short supply since 2022 due to increased demand, but the shortage issue is now resolved. Industry organizations say that FDA's determination equals to pharmacies stopping the allocation and distribution of generic versions of the two drugs.
Demystifying Merck & Co: Insights From 8 Analyst Reviews
Wells Fargo's 'Core' Stocks: GOOGL, HD, KO, and More
Cracking The Code: Understanding Analyst Reviews For Eli Lilly